Close
Nordic 9Nordic 9

Eva Pharma (investor - Others)

United States
See something wrong or missing? Let us know
Offices:Aberdeen
Average round investment:17.07M USD
Average number per year:1.0
Distribution: 2023 (1)2021 (1)
Portfolio companies: United Kingdom SolasCure
Mostly invests in: United Kingdom United Kingdom (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Eva Pharma

Name Criteria
Riyadh Valley Company
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Companion Fund
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada Fonds de solidarité FTQ
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada Novateur Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Monograph Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany L&R Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Sweden Niklas Zennström
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
United Kingdom Pentech
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Japan Taiho Ventures
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany 2invest
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top